Literature DB >> 4078245

More on nomifensine.

A E Pontiroli, L Falsetti.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4078245     DOI: 10.1007/BF03348543

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


× No keyword cloud information.
  7 in total

1.  More on nomifensine.

Authors:  A Liuzzi; P G Chiodini
Journal:  J Endocrinol Invest       Date:  1985-04       Impact factor: 4.256

2.  Benserazide, a stimulator of prolactin release: a new test in the diagnosis of pituitary prolactin-secreting tumours.

Authors:  A E Pontiroli; L Falsetti; A M Voltolini; M Alberetto; G Pellicciotta; A de Pasqua; A M Girardi; G Pozza
Journal:  Acta Endocrinol (Copenh)       Date:  1981-11

3.  Central nervous system-mediated stimulation of prolactin secretion by cimetidine, a histamine H2-receptor antagonist: impaired responsiveness in patients with prolactin-secreting tumors and idiopathic hyperprolactinemia.

Authors:  C Gonzalez-Villapando; M Szabo; L A Frohman
Journal:  J Clin Endocrinol Metab       Date:  1980-12       Impact factor: 5.958

4.  The effect of metoclopramide, TRH and L-dopa on prolactin secretion in pituitary adenoma and in "functional" galactorrhoea syndrome.

Authors:  W Jeske
Journal:  Acta Endocrinol (Copenh)       Date:  1979-07

5.  Development of pituitary adenoma in women with hyperprolactinaemia: clinical, endocrine, and radiological characteristics.

Authors:  A E Pontiroli; L Falsetti
Journal:  Br Med J (Clin Res Ed)       Date:  1984-02-18

6.  Prolactin responsiveness to TRH in amenorrheic women with and without galactorrhea.

Authors:  C MacGregor; D Maldonado; E S Canales; J Soria; A Zárate
Journal:  Acta Obstet Gynecol Scand       Date:  1977       Impact factor: 3.636

7.  Nomifensine: diagnostic test in hyperprolactinemic states.

Authors:  E E Müller; A R Genazzani; S Murru
Journal:  J Clin Endocrinol Metab       Date:  1978-12       Impact factor: 5.958

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.